Bolt Biotherapeutics (BOLT) Assets Average (2021 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Assets Average for 5 consecutive years, with $60.9 million as the latest value for Q4 2025.
- Quarterly Assets Average fell 41.71% to $60.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60.9 million through Dec 2025, down 41.71% year-over-year, with the annual reading at $78.2 million for FY2025, 39.72% down from the prior year.
- Assets Average hit $60.9 million in Q4 2025 for Bolt Biotherapeutics, down from $70.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $340.3 million in Q3 2021 to a low of $60.9 million in Q4 2025.
- Historically, Assets Average has averaged $190.8 million across 5 years, with a median of $184.3 million in 2021.
- Biggest five-year swings in Assets Average: skyrocketed 59.09% in 2022 and later plummeted 41.71% in 2025.
- Year by year, Assets Average stood at $320.6 million in 2021, then decreased by 26.19% to $236.7 million in 2022, then dropped by 29.19% to $167.6 million in 2023, then crashed by 37.65% to $104.5 million in 2024, then tumbled by 41.71% to $60.9 million in 2025.
- Business Quant data shows Assets Average for BOLT at $60.9 million in Q4 2025, $70.3 million in Q3 2025, and $80.7 million in Q2 2025.